Ropes & Gray In Conversation kapak görseli

Ropes & Gray In Conversation

Ropes & Gray In Conversation

Yazan: Ropes & Gray LLP
Şimdi ücretsiz dinle, üyelik gerekmez

This Season's Biggest Deal | £0.99/mo for 3 months + £10 Audible bonus

£5.99/mo after 3 months - terms apply. Cancel monthly
Özet
AI-generated conversations based on our most recent legal updates.© 2026 Economics Politics & Government
  • Who Bears the Risk? EU Court of Justice Clarifies the Boundaries of Distributor and Manufacturer Obligations Under the EU Medical Devices Regulation
    30 Oct 2026

    This episode explores a pivotal EU court ruling on distributor obligations under the Medical Devices Regulation, clarifying due care requirements and reinforcing manufacturers’ primary responsibility for product classification in the medical device supply chain.

    Daha fazlasını göster Daha Az Göster
    3 dk.
  • FDA Launches Pursuit of Fit-For-Purpose Regulatory Framework to Advance Rare Disease Drug Development
    27 Oct 2026

    This episode breaks down the FDA’s new Rare Disease Framework Initiative—launched in October 2026—which aims to consistently apply regulatory flexibility for rare disease therapies by establishing a centralized innovation hub, engaging outside experts, and implementing risk-based approaches to evidence and manufacturing standards.


    Daha fazlasını göster Daha Az Göster
    5 dk.
  • Manhattan District Attorney Launches New Corporate Crime and Antitrust Task Force
    19 Oct 2026

    This episode discusses the Manhattan District Attorney’s new Corporate Crime and Antitrust Task Force, highlighting expanded state-level enforcement risks—including AI-facilitated offenses—for organizations and their leaders, with a focus on "systemic accountability" and heightened scrutiny of key sectors and counterparties.

    Daha fazlasını göster Daha Az Göster
    4 dk.
adbl_web_anon_alc_button_suppression_t1
Henüz yorum yok